Xbira – Advanced Prostate Cancer Treatment

oncology  /  Xbira

Xbira

Xbira is a prescription medication containing Abiraterone Acetate, designed for the treatment of metastatic castration-resistant prostate cancer (mCRPC) in adult men. Xbira works by inhibiting the pro... Xbira is a prescription medication containing Abiraterone Acetate, designed for the treatment of metastatic castration-resistant prostate cancer (mCRPC) in adult men. Xbira works by inhibiting the production of androgens (male hormones) in the body, which are responsible for the growth and spread of prostate cancer cells. By reducing androgen levels, Xbira helps slow the progression of cancer, manage symptoms, and improve the patient’s quality of life. It is typically administered in combination with prednisone or prednisolone to help manage treatment-related side effects. Xbira is an oral medication, providing a convenient treatment option for patients requiring long-term therapy under medical supervision. The use of Xbira as part of a comprehensive treatment plan may help extend survival and maintain comfort for patients facing advanced stages of prostate cancer. Read more Hide

• Active ingredient:
  Abiraterone Acetate
• Manufacturer: Cipla
• Dosage: 250 mg
• Dosage form: Tablets
• Units per pack: 120
• Delivery across Ukraine
• 100% original product